This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
In this article we discuss the challenges for manufacturers of therapeutics and diagnostics as they pursue the potential of companion diagnostics. Click below to read the article.
Several pivotal topics emerged, establishing predominant themes throughout the conference. Although efficacy continues to be the fundamental basis of oncology...
The relationship between ASP dynamics and changes to WAC, both publicly available, offers insight into the apparent level of price concessions for a product....
Is Going to a Private-Equity Owned Hospital Bad for Your Health? Private equity investment in health care has increased more than 20-fold—from $5 billion in...
Erin McDermott moderates the session exploring practical strategies for balancing caregiving responsibilities with professional goals. Caring for a parent,...
